BioCentury
ARTICLE | Company News

Pfizer licenses diabetes compound to ChemRar

July 6, 2012 12:28 AM UTC

Pfizer Inc. (NYSE:PFE) granted the SatRx company of ChemRar High Tech Center (Khimki, Russia) exclusive rights outside China to develop and commercialize Pfizer's PF-00734200 as monotherapy or in comb...